Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...
US-based Thermo Fisher Scientific has announced that the Oncomine™ Comprehensive Assay Plus is now available on th...
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers ...
US-based Waters Corporation and BD (Becton, Dickinson and Company) have announced a definitive agreement to combine...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing soluti...
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, and Sensible Biotechno...
Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...
Japan's Shimadzu Corporation has obtained premarketing notification from the US Food and Drug Administration (FDA) for i...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a l...
Thermo Fisher Scientific, the world leader in serving science, has announced that the US Food and Drug Administration (F...
South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated the start o...
Xcell Biosciences, a San Francisco-based instrumentation company focused on cell and gene therapy applications, has anno...
Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire Som...
As the global antibody-drug conjugate (ADC) market expands — driven by both new therapeutic approvals and growing ...
